Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia.
Farah YasminHala NajeebUnaiza NaeemAbdul MoeedAbdul Raafe AtifMuhammad Sohaib AsgharNayef NimriMaryam SaleemDhrubajyoti BandyopadhyayChayakrit KrittanawongMohammed Mahmmoud Fadel Allah EljackMuhammad Junaid TahirFahad WaqarPublished in: Immunity, inflammation and disease (2023)
Available literature includes more studies with the BNT162b2 vaccine than mRNA-1273. Future studies must report mortality and adverse cardiovascular events by vaccine types.